Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

In vivo and in vitro evaluation of the effect of 2-(4-morpholinethyl)1-phenylcyclohexanecarboxylate on inflammation-sensitized hyperoxia-induced developing brain injury.

Posod A, Krepp Y, Urbanek M, Stock K, Kiechl-Kohlendorfer U, Griesmaier E.

J Neurosci Res. 2013 Nov;91(11):1463-72. doi: 10.1002/jnr.23271. Epub 2013 Aug 23.

PMID:
24038156
2.

The common antitussive agent dextromethorphan protects against hyperoxia-induced cell death in established in vivo and in vitro models of neonatal brain injury.

Posod A, Pinzer K, Urbanek M, Wegleiter K, Keller M, Kiechl-Kohlendorfer U, Griesmaier E.

Neuroscience. 2014 Aug 22;274:260-72. doi: 10.1016/j.neuroscience.2014.05.059. Epub 2014 Jun 6.

PMID:
24912029
3.

Neuroprotective effects of the sigma-1 receptor ligand PRE-084 against excitotoxic perinatal brain injury in newborn mice.

Griesmaier E, Posod A, Gross M, Neubauer V, Wegleiter K, Hermann M, Urbanek M, Keller M, Kiechl-Kohlendorfer U.

Exp Neurol. 2012 Oct;237(2):388-95. doi: 10.1016/j.expneurol.2012.06.030. Epub 2012 Jul 6.

PMID:
22771763
4.

Protective effects of topiramate against hyperoxic brain injury in the developing brain.

Kurul SH, Yiş U, Kumral A, Tuğyan K, Cilaker S, Kolatan E, Yilmaz O, Genç S.

Neuropediatrics. 2009 Feb;40(1):22-7. doi: 10.1055/s-0029-1224101. Epub 2009 Jul 28.

PMID:
19639524
5.

Estradiol attenuates hyperoxia-induced cell death in the developing white matter.

Gerstner B, Sifringer M, Dzietko M, Schüller A, Lee J, Simons S, Obladen M, Volpe JJ, Rosenberg PA, Felderhoff-Mueser U.

Ann Neurol. 2007 Jun;61(6):562-73.

PMID:
17427919
6.

Effect of erythropoietin on oxygen-induced brain injury in the newborn rat.

Yiş U, Kurul SH, Kumral A, Tuğyan K, Cilaker S, Yilmaz O, Genç S, Genç K.

Neurosci Lett. 2008 Dec 31;448(3):245-9. doi: 10.1016/j.neulet.2008.10.060. Epub 2008 Nov 1.

PMID:
18973793
7.

Selective sigma receptor agonist 2-(4-morpholinethyl)1-phenylcyclohexanecarboxylate (PRE084) promotes neuroprotection and neurite elongation through protein kinase C (PKC) signaling on motoneurons.

Guzmán-Lenis MS, Navarro X, Casas C.

Neuroscience. 2009 Aug 4;162(1):31-8. doi: 10.1016/j.neuroscience.2009.03.067. Epub 2009 Apr 5.

PMID:
19345724
8.

Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity.

Marrazzo A, Caraci F, Salinaro ET, Su TP, Copani A, Ronsisvalle G.

Neuroreport. 2005 Aug 1;16(11):1223-6.

PMID:
16012353
9.

Sigma-1 Receptor Modulates Neuroinflammation After Traumatic Brain Injury.

Dong H, Ma Y, Ren Z, Xu B, Zhang Y, Chen J, Yang B.

Cell Mol Neurobiol. 2016 Jul;36(5):639-45. doi: 10.1007/s10571-015-0244-0. Epub 2015 Jul 31.

PMID:
26228028
10.

Sigma receptor agonist 2-(4-morpholinethyl)1 phenylcyclohexanecarboxylate (Pre084) increases GDNF and BiP expression and promotes neuroprotection after root avulsion injury.

Penas C, Pascual-Font A, Mancuso R, Forés J, Casas C, Navarro X.

J Neurotrauma. 2011 May;28(5):831-40. doi: 10.1089/neu.2010.1674. Epub 2011 Apr 12.

PMID:
21332255
11.

The sigma-1 receptor agonist 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) protects against newborn excitotoxic brain injury by stabilizing the mitochondrial membrane potential in vitro and inhibiting microglial activation in vivo.

Wegleiter K, Hermann M, Posod A, Wechselberger K, Stanika RI, Obermair GJ, Kiechl-Kohlendorfer U, Urbanek M, Griesmaier E.

Exp Neurol. 2014 Nov;261:501-9. doi: 10.1016/j.expneurol.2014.07.022. Epub 2014 Aug 8.

PMID:
25111531
12.

Neuroprotective effect of dexmedetomidine on hyperoxia-induced toxicity in the neonatal rat brain.

Sifringer M, von Haefen C, Krain M, Paeschke N, Bendix I, Bührer C, Spies CD, Endesfelder S.

Oxid Med Cell Longev. 2015;2015:530371. doi: 10.1155/2015/530371. Epub 2015 Jan 13.

13.

Erythropoietin protects the developing brain from hyperoxia-induced cell death and proteome changes.

Kaindl AM, Sifringer M, Koppelstaetter A, Genz K, Loeber R, Boerner C, Stuwe J, Klose J, Felderhoff-Mueser U.

Ann Neurol. 2008 Nov;64(5):523-34. doi: 10.1002/ana.21471.

PMID:
19067366
14.

Deleterious effect of hyperoxia at birth on white matter damage in the newborn rat.

Vottier G, Pham H, Pansiot J, Biran V, Gressens P, Charriaut-Marlangue C, Baud O.

Dev Neurosci. 2011;33(3-4):261-9. doi: 10.1159/000327245. Epub 2011 Jun 10.

PMID:
21659719
15.

Neuroprotection by Caffeine in Hyperoxia-Induced Neonatal Brain Injury.

Endesfelder S, Weichelt U, Strauß E, Schlör A, Sifringer M, Scheuer T, Bührer C, Schmitz T.

Int J Mol Sci. 2017 Jan 18;18(1). pii: E187. doi: 10.3390/ijms18010187.

16.

Oxygen toxicity is reduced by acetylcholinesterase inhibition in the developing rat brain.

Sifringer M, Bendix I, von Haefen C, Endesfelder S, Kalb A, Bührer C, Felderhoff-Mueser U, Spies CD.

Dev Neurosci. 2013;35(2-3):255-64. doi: 10.1159/000346723. Epub 2013 Feb 27.

PMID:
23445753
17.

Hyperoxia changes the balance of the thioredoxin/peroxiredoxin system in the neonatal rat brain.

Bendix I, Weichelt U, Strasser K, Serdar M, Endesfelder S, von Haefen C, Heumann R, Ehrkamp A, Felderhoff-Mueser U, Sifringer M.

Brain Res. 2012 Nov 12;1484:68-75. doi: 10.1016/j.brainres.2012.09.024. Epub 2012 Sep 21.

PMID:
23006780
18.

Zonisamide attenuates hyperoxia-induced apoptosis in the developing rat brain.

Topçu Y, Bayram E, Ozbal S, Yiş U, Tuğyan K, Karaoğlu P, Kumral A, Yılmaz O, Kurul SH.

Neurol Sci. 2014 Nov;35(11):1769-75. doi: 10.1007/s10072-014-1834-1. Epub 2014 Jun 11.

PMID:
24916835
19.

The σ 1 receptor agonist 4-PPBP elicits ERK1/2 phosphorylation in primary neurons: a possible mechanism of neuroprotective action.

Tan F, Guio-Aguilar PL, Downes C, Zhang M, O'Donovan L, Callaway JK, Crack PJ.

Neuropharmacology. 2010 Nov;59(6):416-24. doi: 10.1016/j.neuropharm.2010.05.014. Epub 2010 Jun 9.

PMID:
20538010
20.

Dimemorfan protects rats against ischemic stroke through activation of sigma-1 receptor-mediated mechanisms by decreasing glutamate accumulation.

Shen YC, Wang YH, Chou YC, Liou KT, Yen JC, Wang WY, Liao JF.

J Neurochem. 2008 Jan;104(2):558-72. doi: 10.1111/j.1471-4159.2007.05058.x.

Supplemental Content

Support Center